Oxford Cancer Analytics Appoints Dr. Heinrich Roder as Senior Vice President, Research & Development

PRIVATEJan 09, 2025

Company

Oxford Cancer Analytics

OxfordBiotechnologyHealth CareArtificial IntelligenceHealth Diagnostics

Description

OXcan has raised US$11 million in Series A funding, and appointed Dr. Heinrich Roder as Senior Vice President, Research & Development. The funding positions the company to develop and globally commercialize its new generation of minimally invasive liquid biopsy blood tests for the early detection of lung cancer.

Quick answer

Oxford Cancer Analytics Appoints Dr. Heinrich Roder as Senior Vice President, Research & Development (January 9, 2025). Oxford Cancer Analytics is based in Oxford, England, United Kingdom.

What did Oxford Cancer Analytics announce on January 9, 2025?: OXcan has raised US$11 million in Series A funding, and appointed Dr. Heinrich Roder as Senior Vice President, Research & Development. The funding positions the company to develop and globally commercialize its new generation of minimally invasive liquid biopsy blood tests for the early detection of lung cancer.
What does Oxford Cancer Analytics do?: Oxford Cancer Analytics Ltd (OXcan) is on a mission to enable curative cancer treatments through early detection.
Where is Oxford Cancer Analytics based?: Oxford Cancer Analytics is based in Oxford, England, United Kingdom.

Source: Fundz verified event record.

Who to call at Oxford Cancer Analytics, and when

A new leader at Oxford Cancer Analytics brings new priorities and often new vendors. The first weeks are when they listen.

An alert the day Oxford Cancer Analytics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Oxford Cancer Analytics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Oxford Cancer Analytics. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Oxford Cancer Analytics

Location

Oxford, England, United Kingdom

About

Oxford Cancer Analytics Ltd (OXcan) is on a mission to enable curative cancer treatments through early detection. OXcan's machine learning platform enables minimally invasive and inexpensive cancer screening in high risk populations through analysing cancer materials shed into the blood. OXcan hopes to create a paradigm shift in screening and eventually replacing invasive tissue biopsy and expensive, complex imaging as the current standard of care. It is safer, cheaper, and detects cancers much earlier, when they are still curable.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Oxford Cancer Analytics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans